Application of permeability-limited physiologically-based pharmacokinetic models: Part I–digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux
2013 ◽
Vol 102
(9)
◽
pp. 3145-3160
◽
2013 ◽
Vol 102
(9)
◽
pp. 3161-3173
◽
2012 ◽
Vol 9
(5)
◽
pp. 1971-1983
◽
2012 ◽
Vol 93
(2)
◽
pp. 152-152
◽
2018 ◽
Vol 58
(2)
◽
pp. 235-262
◽
2020 ◽
pp. 301-321
2017 ◽
Vol 106
(9)
◽
pp. 2758-2770
◽